The four components
Each name is a different molecule. They share a vial or a pen. They do not share one sequence.
| Component | What it is | Labeled amount |
|---|---|---|
| KPV | The Lys-Pro-Val tripeptide. Papers on the seller’s reading list also describe it as the C-terminal tripeptide of alpha-melanocyte-stimulating hormone.3 | 10 mg |
| BPC-157 | The synthetic 15-amino-acid peptide. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. That sequence belongs to this component. It is not the sequence of KLOW.4 | 10 mg |
| TB-500 | On this label, the seller’s synthetic actin-binding fragment of thymosin beta-4. The Accumark certificate for the pen names the analyte “TB500 (17–23 Fragment).”1,5 | 10 mg |
| GHK-Cu | The copper complex of glycyl-L-histidyl-L-lysine. The seller notes that this component can leave the liquid clear to lightly blue-tinted.2,6 | 50 mg |
Labeled amounts
The pen and the vial carry the same four amounts. The concentrations differ because the volumes differ.
| Pen, 3 mL | Vial, 10 mL | |
|---|---|---|
| KPV | 10 mg · about 3.33 mg/mL | 10 mg · 1 mg/mL |
| BPC-157 | 10 mg · about 3.33 mg/mL | 10 mg · 1 mg/mL |
| TB-500 | 10 mg · about 3.33 mg/mL | 10 mg · 1 mg/mL |
| GHK-Cu | 50 mg · about 16.67 mg/mL | 50 mg · 5 mg/mL |
A lot certificate can measure different milligrams than the label. The Accumark certificate for pen lot KL102126 reports a measured total of 77.046 mg against 80.0 mg declared. Those measured figures are on the testing page. They are not a replacement for the label amounts above.
What KLOW is not
- Not one chain. Four peptides share the solution. BPC-157’s 15 residues are one of those peptides.
- Not an approved drug. KLOW as sold is not an FDA-approved drug. It is labeled for laboratory research use only.1
- Not a studied combination. There is no published study of this four-peptide pen or vial as one product. The research page says what the component papers actually are.
- Not a use protocol. This site does not give dosing, click-count instructions for use, or a reconstitution guide. Both catalog formats are already in aqueous solution.
Where the papers fit
The seller’s KLOW reading list is five papers. Each one is about one component, or about the longer thymosin beta-4 molecule. None of them is a study of this pen or vial.
Authors are cited for their papers. They did not write, review, or endorse this site. Read the five papers in plain language →
Sources
Study authors are credited for their published research. None of them wrote, reviewed, or endorsed this site.
- Palm Beach Vitality. KLOW Pen product page, checked November 18, 2026. palmbeach-vitality.store
- Palm Beach Vitality. KLOW Vial product page, checked November 18, 2026. palmbeach-vitality.store
- Getting SJ, Schiöth HB, Perretti M. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. J Pharmacol Exp Ther. 2003;306(2):631–637. PMID 12750433
- National Center for Biotechnology Information. PubChem Compound Summary for CID 9941957, BPC-157. pubchem.ncbi.nlm.nih.gov
- Accumark Labs. Certificate of analysis for KLOW Pen, sample 8V4W-UP8E, lot KL102126, published October 26, 2026. Shown on the testing page.
- Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969–988. PMID 18644225